Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B
10.1111/j.1365-2036.2008.03686.x
Saved in:
Main Authors: | Lim, S.G., Leung, N., Hann, H.W.L., Lau, G.K.K., Trepo, C., Mommeja-Marin, H., Moxham, C., Sorbel, J., Snow, A., Blum, M.R., Rousseau, F., Marcellin, P. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2011
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/26670 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011) -
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
by: Jyoti S. Mathad, et al.
Published: (2022) -
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
by: Mathad J.S.
Published: (2023) -
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
by: Marcellin, P., et al.
Published: (2016) -
The pharmacokinetics of quinine in patients with hepatitis.
by: J. Karbwang, et al.
Published: (2018)